Latest filing published 20 Aug 2026 for DEXCOM, INC., €2.1M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kevin R Sayer: trading record in brief
Kevin R Sayer discloses dealings in Dexcom Inc to SEC (Form 4). Over a trading history stretching from 6 July 2026 to 20 August 2026, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 20 August 2026, the filings show a transaction worth €2.1M in Dexcom Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kevin R Sayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,756 shares@ US$90.0075CommonSEC144:0001950047-26-008475
- 26,756 shares@ US$76.31930.100% mcap51.5% of flowCommonSEC144:0001950047-26-007209
- 26,756 shares@ US$72.00100.0% of flowCommonSEC144:0001950047-26-006860
3 of 3 declarations
